These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38608008)

  • 1. Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
    Moar P; Linn K; Premeaux TA; Bowler S; Sardarni UK; Gopalan BP; Shwe EE; San T; Han H; Clements D; Hlaing CS; Kyu EH; Thair C; Mar YY; Nway N; Mannarino J; Bolzenius J; Mar S; Aye AMM; Tandon R; Paul R; Ndhlovu LC
    AIDS; 2024 Aug; 38(10):1460-1467. PubMed ID: 38608008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
    Premeaux TA; Moser CB; McKhann A; Hoenigl M; Laws EI; Aquino DL; Lederman MM; Landay AL; Gianella S; Ndhlovu LC;
    AIDS; 2021 Dec; 35(15):2489-2495. PubMed ID: 34366381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy.
    Premeaux TA; Javandel S; Hosaka KRJ; Greene M; Therrien N; Allen IE; Corley MJ; Valcour VG; Ndhlovu LC
    Front Immunol; 2020; 11():1321. PubMed ID: 32695109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
    Premeaux TA; D'Antoni ML; Abdel-Mohsen M; Pillai SK; Kallianpur KJ; Nakamoto BK; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Gisslén M; Price RW; Valcour V; Ndhlovu LC
    J Neurovirol; 2019 Apr; 25(2):150-161. PubMed ID: 30478799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV.
    Kim-Chang JJ; Donovan K; Loop MS; Hong S; Fischer B; Venturi G; Garvie PA; Kohn J; Rendina HJ; Woods SP; Goodenow MM; Nichols SL; Sleasman JW;
    AIDS; 2019 Dec; 33(15):2363-2374. PubMed ID: 31764101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.
    Shete A; Dhayarkar S; Dhamanage A; Kulkarni S; Ghate M; Sangle S; Medhe U; Verma V; Rajan S; Hattori T; Gangakhedkar R
    AIDS Res Ther; 2020 Jul; 17(1):43. PubMed ID: 32678033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
    D'Souza RR; Gopalan BP; Rajnala N; Phetsouphanh C; Shet A
    HIV Med; 2019 Sep; 20(8):513-522. PubMed ID: 31131542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Function among HIV Infected Children in Pune.
    Ghate M; Narkhede H; Rahane G; Nirmalkar A; Gaikwad N; Kadam D
    Indian J Pediatr; 2015 Jun; 82(6):515-8. PubMed ID: 25432090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-Related Cognitive Impairment of Orphans in Myanmar With Vertically Transmitted HIV Taking Antiretroviral Therapy.
    Linn K; Fay A; Meddles K; Isbell S; Lin PN; Thair C; Heaps J; Paul R; Mar SS
    Pediatr Neurol; 2015 Dec; 53(6):485-490.e1. PubMed ID: 26386698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-associated cognitive disorders in perinatally infected children and adolescents: a novel composite cognitive domains score.
    Phillips NJ; Hoare J; Stein DJ; Myer L; Zar HJ; Thomas KGF
    AIDS Care; 2018; 30(sup1):8-16. PubMed ID: 29681168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.
    Tandon R; Chew GM; Byron MM; Borrow P; Niki T; Hirashima M; Barbour JD; Norris PJ; Lanteri MC; Martin JN; Deeks SG; Ndhlovu LC
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):654-64. PubMed ID: 24786365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid decrease of plasma galectin-9 levels in patients with acute HIV infection after therapy.
    Saitoh H; Ashino Y; Chagan-Yasutan H; Niki T; Hirashima M; Hattori T
    Tohoku J Exp Med; 2012 Oct; 228(2):157-61. PubMed ID: 23038209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents.
    Alvarez P; Mwamzuka M; Marshed F; Kravietz A; Ilmet T; Ahmed A; Borkowsky W; Khaitan A
    PLoS One; 2017; 12(12):e0190332. PubMed ID: 29287090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).
    Frigati LJ; Brown K; Mahtab S; Githinji L; Gray D; Zühlke L; Nourse P; Stein DJ; Hoare J; Cotton MF; Myer L; Zar HJ
    J Int AIDS Soc; 2019 Aug; 22(8):e25386. PubMed ID: 31441211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice.
    Yuan Z; Giron LB; Hart C; Gyampoh A; Koshy J; Hong KY; Niki T; Premeaux TA; Ndhlovu LC; Deleage C; Montaner LJ; Abdel-Mohsen M
    AIDS; 2023 Mar; 37(4):571-577. PubMed ID: 36460646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India.
    Kausalya B; Saravanan S; Pallikkuth S; Pahwa R; Saini SR; Iqbal S; Solomon S; Murugavel KG; Poongulali S; Kumarasamy N; Pahwa S
    BMC Immunol; 2022 May; 23(1):24. PubMed ID: 35581554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary dysfunction in perinatally HIV-infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort.
    Githinji LN; Mahtab S; Zühlke L; Lawrenson J; Myer L; Gray D; Zar H
    J Int AIDS Soc; 2019 Jul; 22(7):e25340. PubMed ID: 31291058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.
    Krebs SJ; Slike BM; Sithinamsuwan P; Allen IE; Chalermchai T; Tipsuk S; Phanuphak N; Jagodzinski L; Kim JH; Ananworanich J; Marovich MA; Valcour VG;
    AIDS; 2016 Jun; 30(10):1533-42. PubMed ID: 26990631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.
    Colomb F; Giron LB; Premeaux TA; Mitchell BI; Niki T; Papasavvas E; Montaner LJ; Ndhlovu LC; Abdel-Mohsen M
    Front Immunol; 2019; 10():267. PubMed ID: 30842775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies.
    Ka'e AC; Nanfack AJ; Ambada G; Santoro MM; Takou D; Semengue ENJ; Nka AD; Bala MLM; Endougou ON; Elong E; Beloumou G; Djupsa S; Gouissi DH; Fainguem N; Tchouaket MCT; Sosso SM; Kesseng D; Ndongo FA; Sonela N; Kamta ACL; Tchidjou HK; Ndomgue T; Ndiang STM; Nlend AEN; Nkenfou CN; Montesano C; Halle-Ekane GE; Cappelli G; Tiemessen CT; Colizzi V; Ceccherini-Silberstein F; Perno CF; Fokam J
    Front Immunol; 2023; 14():1239877. PubMed ID: 37646023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.